BioSpace News Archive

Biotricity, Inc. , a medical diagnostic and consumer healthcare technology company, is pleased to announce that CEO Waqaas Al-Siddiq will present at Maxim Groups Inaugural Emerging Growth Virtual Conference to be held March 17-19, 2021.

Lygos, Inc., a vertically integrated provider of safe and sustainable specialty ingredients, today announced that it is working with the U.S. Department of Energy Bioenergy Technologies Office’s Agile BioFoundry (ABF) to generate the largest multi-omics dataset for guiding the development of organic acids.

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announced that PEPAXTO® (melphalan flufenamide) is now commercially available and that the first patients are being treated with the drug.

Continued Strong Growth and Increasing Momentum for Invisalign Clear Aligners and iTero Systems and Services Across Products and Customer Channels Worldwide, Reflects the Strength of Align’s Doctor-Directed Model and the Align Digital Platform

NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announces that Nanox’s Founder and Chief Executive Officer Ran Poliakine will deliver a company presentation and the leadership team will host investor 1x1 meetings during the Oppenheimer 31st Annual Virtual Healthcare Conference

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP), in collaboration with Pfizer Inc., announces ten projects have been chosen to receive funding to support innovative approaches to improve the processes related to appropriate biosimilar adoption in oncology.

The Safety in Spine Surgery Project has announced the Best New Methodologies and Techniques to Enhance Safety in Spine Surgery for 2021.

Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) (“Company”) announced today that in studies conducted at Galveston National Laboratory (GNL), University of Texas Medical Branch (UTMB) at Galveston, hamsters challenged with the virus that causes COVID-19 (SARS-CoV-2), resulted in decreased inflammation in the lungs of animals treated with Tempol compared to controls.

BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a leading pre-clinical-stage biotechnology company focused on harnessing elements of Perinatal Tissue for use in regenerative therapies, today announced it engaged D. Brooks and Associates CPA’s, P.A. as the Company’s PCAOB registered certified public accounting firm for the 2020 and 2019 fiscal years.

The American Cancer Society is a global grassroots force of nearly 2 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer.